Genome Wide Association Study for Predictors of Progression Free Survival in Patients on Capecitabine, Oxaliplatin, Bevacizumab and Cetuximab in First-Line Therapy of Metastatic Colorectal Cancer

Author(s):: Pander, J.; Huis-Tanja, L. van; Bohringer, S.; Straaten, T. van der; Gelderblom, H.; Punt, C.; Guchelaar, H.J. (0000-0002-7085-1383)

Published: 2015
Publication type: Article / Letter to editor

Date issued: 2015-07-29
Language: English
Is part of: PLoS ONE (2015), No. 7
hdl: 1887/105175
doi: 10.1371/journal.pone.0131091